* Cyclo Therapeutics Inc CYTH.OQ CYTH.O is expected
to show a
fall in quarterly revenue when it reports results on August 14
(estimated).
* The Gainesville Florida Florida-based company is expected
to
report a 26.8% decrease in revenue to $396 thousand from $541
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cyclo Therapeutics
Inc is
for a loss of 44 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated August 12 at 01:03 GMT. All
figures in US dollars unless otherwise stated